Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/9433
Title: | Synthesis, beta-adrenoceptor pharmacology and toxicology of S-(-)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride, a short acting beta(1)-specific antagonist. | Austin Authors: | Jackman, Graham P;Iakovidis, Dimitri;Nero, Tracy L;Anavekar, Nagesh S;Rezmann-Vitti, Linda A;Louis, Simon N S;Mori, Masanori;Drummer, Olaf H;Louis, William J | Affiliation: | Clinical Pharmacology and Therapeutics Unit, Department of Medicine, Austin and Repatriation Medical Centre, The University of Melbourne, Heidelberg, Vic 3084, Australia | Issue Date: | 1-Sep-2002 | Publication information: | European Journal of Medicinal Chemistry; 37(9): 731-41 | Abstract: | The synthesis of S-(-)-1-(4-(2-ethoxyethoxy)phenoxy)-2-hydroxy-3-(2-(3,4-dimethoxyphenyl)ethylamino)propane hydrochloride (D140S.HCl 6), a novel short acting beta(1)-specific adrenoceptor antagonist, has been described. The antagonist potency for D140S.HCl 6 has been compared with esmolol, another short acting agent, and other well known beta-adrenoceptor antagonists in isolated rat tissue preparations. The pharmacokinetics of D140S.HCl 6 in 7 day continuous intravenous infusions and 4 weeks intravenous bolus injection studies in conscious rats and dogs have been examined in toxicology studies. The effect on the isoprenaline-induced heart rate increase and the pharmacodynamic half-life of D140S.HCl 6 has been compared with esmolol in a conscious rat model. In addition, the results of a range of toxicological studies are presented. The results indicate that D140S.HCl 6 is a highly specific beta(1)-adrenoceptor antagonist (pA(2) = 8.15+/-0.22, beta(1)/beta(2) selectivity > 4400). The in vitro studies suggest D140S.HCl is ca. ten times more potent and 60 times more beta(1)-specific than racemic esmolol. Pharmacokinetic non-linearity was seen when given as a 7 day intravenous infusion at toxicological doses above 10 mg kg(-1) h(-1) in the rat and 2.5 mg kg(-1) h(-1) in the dog. Both D140S.HCl 6 and esmolol have very short durations of action after intravenous infusion in the rat (pharmacodynamic half-life is < 15 min for D140S.HCl and 10 min for esmolol). The toxicological tests indicate that D140S.HCl 6 shows no unexpected toxicity and none of the tissue irritancy problems reported for esmolol formulations. | Gov't Doc #: | 12350290 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/9433 | Journal: | European journal of medicinal chemistry | URL: | https://pubmed.ncbi.nlm.nih.gov/12350290 | Type: | Journal Article | Subjects: | Adrenergic beta-1 Receptor Agonists Adrenergic beta-Agonists.chemical synthesis.pharmacology.toxicity Adrenergic beta-Antagonists.pharmacology Animals Atenolol.pharmacology Chromatography, High Pressure Liquid Dogs Female Half-Life Heart Atria.drug effects In Vitro Techniques Infusions, Intravenous Magnetic Resonance Spectroscopy Myocardial Contraction.drug effects Propane.analogs & derivatives.chemical synthesis.pharmacology Propanolamines.pharmacology Rats Rats, Sprague-Dawley Trachea.drug effects |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.